MHRA Drug Safety Update: Semaglutide and risk of non-arteritic anterior ischaemic optic neuropathy
It is unclear how long treatment must continue to maintain weight loss, and whether chronic therapy is needed (as in adults)especially since drug cessation leads to rapid weight regain (35)
10.1016/j.cmet.2020.02.003 [DOI] [PMC free article] [PubMed] [Google Scholar] Pan L, Hao W, Xue Y et al (2023) 8-Oxoguanine targeted by 8-oxoguanine DNA glycosylase 1 (OGG1) is central to fibrogenic gene activation upon lung injury
On average, participants taking the higher dose lost 18.7% of their body weight
Together, these trends underscore a preference for approachable, ingredients-led products that promise visible results and resonate with selfcare rituals
Nausea, vomiting, and constipation occur in 20-40% of patients, typically during dose escalation, and may limit food intake independent of appetite suppression